Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy
-
- HINOI Toshihide
- Department of Internal Medicine, Kure Kyosai Hospital
-
- TOMOHIRO Yasuyuki
- Department of Internal Medicine, Kure Kyosai Hospital
-
- KAJIWARA Shinji
- Department of Internal Medicine, Kure Kyosai Hospital
-
- MATSUO Syusuke
- Department of Internal Medicine, Kure Kyosai Hospital
-
- FUJIMOTO Yukihiro
- Department of Internal Medicine, Kure Kyosai Hospital
-
- YAMAMOTO Shu
- Department of Cardiovascular Surgery, Kure Kyosai Hospital
-
- SHICHIJO Takeshi
- Department of Cardiovascular Surgery, Kure Kyosai Hospital
-
- ONO Tetuya
- Department of Internal Medicine, Kure Kyosai Hospital
Search this article
Journal
-
- Hypertens Res
-
Hypertens Res 31 (4), 615-622, 2008-04-01
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1572824500453219968
-
- NII Article ID
- 10021934388
-
- NII Book ID
- AA10847079
-
- ISSN
- 09169636
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles